Home
GMS Ventures & Investments reported a 41.6% stake in Outlook Therapeutics OTLK · 16,183,787 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 41.6%
- Last report
- 38.6% · filed 25/01/22
- Shares held
- 16,183,787 sh
- Class
- Common Stock, par value $0.01 per share
- Event date
- 25/03/11
- Filed
- 25/03/12
41.6% stake · +3.0pp from the last report
- Stake
- 41.6%
- Last report
- 38.6%
- Since last report
- +3.0pp
Outlook Therapeutics trades, last 26 weeks
What else happened in Outlook Therapeutics around then
Filed or reported within 30 days of the trade day · 25/02/09~25/04/10GMS Ventures & Investments's other 5% stake reports
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
16.4% stake
42,631,142 sh
16.4% stake
Filed 08/14
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
22.9% stake
37,580,638 sh
22.9% stake
Filed 06/01
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
50.3% stake
29,040,929 sh
50.3% stake
Filed 25/05/28
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
38.6% stake
12,725,216 sh
38.6% stake
Filed 25/01/22